These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10600003)

  • 1. Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.
    Perosa F; Prete M; Luccarelli G; Favoino B; Ferrone S; Dammacco F
    Hum Immunol; 1999 Nov; 60(11):1058-66. PubMed ID: 10600003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression.
    Perosa F; Prete M; Luccarelli G; Favoino B; Dammacco F
    Eur J Immunogenet; 2002 Oct; 29(5):409-12. PubMed ID: 12358850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
    Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
    Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotype.
    Puppo F; Bignardi D; Contini P; Hamby CV; Brenci S; Lanza L; Ghio M; Scudeletti M; Indiveri F; Ferrone S
    Tissue Antigens; 1999 Mar; 53(3):253-62. PubMed ID: 10203018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
    Puppo F; Brenci S; Contini P; Bignardi D; Hamby CV; Filaci G; Ghio M; Scudeletti M; Picciotto A; Indiveri F; Ferrone S
    Tissue Antigens; 2000 Apr; 55(4):333-41. PubMed ID: 10852385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma.
    Perosa F; Luccarelli G; Prete M; Ferrone S; Dammacco F
    Br J Haematol; 1999 Sep; 106(4):987-94. PubMed ID: 10520002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.
    Migliaresi S; Bresciani A; Ambrosone L; Spera M; Barbarulo D; Lombari V; Pirozzi G; Borgia G; Lombardi ML; Tirri G; Manzo C
    Ann Rheum Dis; 2000 Jan; 59(1):20-5. PubMed ID: 10627422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals.
    Zavazava N; Westphal E; Müller-Ruchholtz W
    J Immunogenet; 1990 Dec; 17(6):387-94. PubMed ID: 2096183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients.
    Gelder FB; McDonald JC; Landreneau MD; McMillan RM; Aultman DF
    Ann Surg; 1991 Jun; 213(6):591-7; discussion 597-9. PubMed ID: 2039290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of soluble HLA-G plasma levels with HLA-G alleles.
    Rebmann V; van der Ven K; Pässler M; Pfeiffer K; Krebs D; Grosse-Wilde H
    Tissue Antigens; 2001 Jan; 57(1):15-21. PubMed ID: 11169254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992.
    Pouletty P; Ferrone S; Amesland F; Cohen N; Westhoff U; Charron D; Shimizu RM; Grosse-Wilde H
    Tissue Antigens; 1993 Jul; 42(1):45-54. PubMed ID: 7504328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
    Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
    J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification and identification of soluble HLA-G isoforms.
    Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble HLA-G circulates in maternal blood during pregnancy.
    Hunt JS; Jadhav L; Chu W; Geraghty DE; Ober C
    Am J Obstet Gynecol; 2000 Sep; 183(3):682-8. PubMed ID: 10992193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma.
    Perosa F; Prete M; Luccarelli G; Dammacco F
    Br J Haematol; 2003 Jan; 120(1):36-43. PubMed ID: 12492574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27.
    Ding J; Feng Y; Zheng ZH; Li XY; Wu ZB; Zhu P
    Int J Immunogenet; 2015 Feb; 42(1):4-10. PubMed ID: 25545293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
    Parolini F; Biswas P; Serena M; Sironi F; Muraro V; Guizzardi E; Cazzoletti L; Scupoli MT; Gibellini D; Ugolotti E; Biassoni R; Beretta A; Malnati M; Romanelli MG; Zipeto D
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection.
    DeVito-Haynes LD; Demaria S; Bushkin Y; Burlingham WJ
    Hum Immunol; 1998 Jul; 59(7):426-34. PubMed ID: 9684992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.